AIP;MMF · Remission Rates of Type I Autoimmune Pancreatits With High-risk of Recurrence
Primary completion pushed from Mar 31, 2027 to Sep 30, 2029
Also in this update: Primary endpoint(s) modified; Study completion pushed from Jul 31, 2027 to Sep 30, 2029
Ruijin HospitalPhase 4 NCT06468709 Registry history of NCT06468709 on ClinicalTrials.gov (opens the registry)